Reproducibility of cardiovascular autonomic tests in diabetics with and without autonomic dysfunction and in normal controls

1986 ◽  
Vol 23 (4) ◽  
pp. 323-329 ◽  
Author(s):  
Giancarlo Comi ◽  
Maria Grazia Natali Sora ◽  
Maria Felice Ghilardi ◽  
Nicola Canal ◽  
Gabriella Galimberti ◽  
...  
2014 ◽  
Vol 17 (4) ◽  
pp. 87-92 ◽  
Author(s):  
Dmitriy Nikitich Laptev

Aim. Glucose variability (GV) and hypoglycaemia frequency and duration, depending on cardiovascular autonomic dysfunction, in children and adolescents with type 1 diabetes mellitus (T1DM) were evaluated. Materials and methods. One hundred and thirty T1DM patients, aged 6?18 years, were included in this study. The study included 3 tests:. continuous glucose monitoring (CGM) with GV evaluation, frequency and duration of hypoglycaemia;24-h ECG monitoring with automatic calculation of QTc interval and heart rate variability (HRV) parameters;cardiovascular autonomic tests.Results. The estimated prevalence of cardiovascular autonomic neuropathy (CAN) was 19.2%. CAN positive (CAN+) patients had lower values from cardiovascular autonomic tests and HRV and longer QTc intervals compared with CAN negative (CAN-) patients (p 


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 10099-10099
Author(s):  
Mark Allen O'Rourke ◽  
Regina A. Franco ◽  
Jameson Sofge ◽  
Jay Ginsberg ◽  
Kerri Susko ◽  
...  

10099 Background: Late effects of cancer and its treatment include pain, fatigue, stress, and depression all mediated by autonomic dysfunction. Heart Rate Variability (HRV) coherence is an established measure of autonomic dysfunction. Cancer survivors have lower HRV coherence than normal controls. HRV biofeedback (HRV-B) training improves HRV coherence, restores autonomic health, and reduces the above symptoms. This report describes a feasibility study of HRV-B in symptomatic cancer survivors. Methods: In a randomized, waitlist controlled, clinical trial, 179 were screened, 34 enrolled and 31 completed the protocol. Participants in the intervention arm received weekly HRV-B training up to six weeks. Outcome measures assessed at baseline (pre) and after week six (post) included HRV coherence plus Insomnia Symptom Questionnaire (ISQ), Suscro Distress Inventory (SDI), Brief Pain Inventory (BPI), Multi-Dimensional Fatigue Inventory (MFI), Perceived Stress Scale (PSS) and Beck Depression Inventory II (BDI-II). Results: See table below. Conclusions: Delivering HRV Biofeedback training to cancer survivors is feasible at our Cancer Institute. This pilot study provides preliminary evidence that HRV-B for cancer survivors improves HRV coherence and reduces insomnia, pain, fatigue, depression, and stress. The intervention has great potential and further research is indicated. [Table: see text]


2003 ◽  
Vol 10 (2) ◽  
pp. 67-71 ◽  
Author(s):  
Peter Hobson ◽  
Waliul Islam ◽  
Sally Roberts ◽  
Vedamurthy Adhiyman ◽  
Jolyon Meara

Brain ◽  
1995 ◽  
Vol 118 (5) ◽  
pp. 1319-1327 ◽  
Author(s):  
Lars Lykke Thomsen ◽  
Helle Klingenberg Iversen ◽  
Finn Boesen ◽  
Jes Olesen

Author(s):  
Roland D. Thijs ◽  
Michele Brignole ◽  
Cristian Falup-Pecurariu ◽  
Alessandra Fanciulli ◽  
Roy Freeman ◽  
...  

AbstractAn expert committee was formed to reach consensus on the use of tilt table testing (TTT) in the diagnosis of disorders that may cause transient loss of consciousness (TLOC) and to outline when other provocative cardiovascular autonomic tests are needed. While TTT adds to history taking, it cannot be a substitute for it. An abnormal TTT result is most meaningful if the provoked event is recognised by patients or eyewitnesses as similar to spontaneous events. The minimum requirements to perform TTT are a tilt table, a continuous beat-to-beat blood pressure monitor, at least one ECG lead, protocols for the indications stated below and trained staff. This basic equipment lends itself to the performance of (1) additional provocation tests, such as the active standing test, carotid sinus massage and autonomic function tests; (2) additional measurements, such as video, EEG, transcranial Doppler, NIRS, end-tidal CO2 or neuro-endocrine tests; and (3) tailor-made provocation procedures in those with a specific and consistent trigger of TLOC. TTT and other provocative cardiovascular autonomic tests are indicated if the initial evaluation does not yield a definite or highly likely diagnosis, but raises a suspicion of (1) reflex syncope, (2) the three forms of orthostatic hypotension (OH), i.e. initial, classic and delayed OH, as well as delayed orthostatic blood pressure recovery, (3) postural orthostatic tachycardia syndrome or (4) psychogenic pseudosyncope. A therapeutic indication for TTT is to teach patients with reflex syncope and OH to recognise hypotensive symptoms and to perform physical counter manoeuvres.


1997 ◽  
Vol 55 (2) ◽  
pp. 227-230
Author(s):  
Leila M.B. Araujo ◽  
Roy Freeman ◽  
Christoferson Broadbridge

The aim of this report was to study the cardiovascular autonomic tests in the evaluation of diabetic patients with gastroparesis. Forty diabetic subjects were divided into two groups: one group with gastroparesis (GP, n=20) and another group paired by age and duration of diabetes without any complaint of autonomic neuropathy (DC, n=20) . They were evaluated clinically and submitted to a battery of five cardiovascular autonomic tests. The presence and severity of autonomic neuropathy were defined according to the number of normal cardiovascular tests. Each test had a score: zero ( normal ), one ( borderline ) and two ( abnormal ). The GP group showed a higher abnormal total score in the cardiovascular autonomic test than the group without any complaint (6.6 ± 3.0 vs. 2.7 ± 1.4, p <0.01). These data suggest that diabetic with gastroparesis presents more abnormal cardiovascular autonomic tests than diabetic without autonomic neuropathy and these tests should be included in the evaluation of diabetic patients with gastroparesis.


Sign in / Sign up

Export Citation Format

Share Document